SERA earnings: real EPS beat/miss history, analyst consensus Buy, P/E -3.20. Updated 2026-07-23.
Sera Prognostics (SERA) Research Hub
Sera Prognostics (SERA) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-09-11, shares last closed at 2.03 USD (+1.50%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.20, market cap 0.08B. This hub links to the full technical, earnings and options research available for SERA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.03 USD (+1.50%) |
| 52-week range | 1.73 USD – 2.3 USD |
| Trend regime | Range |
| 14-day RSI | 47.1 (Neutral) |
| Trailing P/E | -3.20 |
| Market cap | 0.08B |
| Dividend yield | 0.00% |
Available research for SERA
Covered Call on SERA: how it works, illustrative setup around the real 2.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SERA: how it works, illustrative setup around the real 2.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SERA: how it works, illustrative setup around the real 2.03 USD price, max profit/loss, breakeven and when to use it. Educational.
SERA technical analysis: range, last 2.03 USD, RSI 47.1, 52w range 1.73 USD–2.3 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is SERA in?
Sera Prognostics (SERA) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.
Is SERA in an uptrend or downtrend?
As of 2026-09-11, SERA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SERA's trailing P/E ratio?
SERA's trailing P/E is -3.20, with a market cap of 0.08B. See the earnings research page for full valuation detail.